Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN

Cell

Volumn 95, Issue 1, 1998, Pages 29-39

  Stambolic, Vuk ^a,b   Suzuki, Akira ^a,b   De la Pompa, José Lois ^a,b   Brothers, Greg M ^a,b   Mirtsos, Christine ^a,b   Sasaki, Takehiko ^a,b   Ruland, Jurgen ^a,b   Penninger, Josef M ^a,b   Siderovski, David P ^a,b   Mak, Tak W ^a,b  

^a AMGEN INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; PROTEIN TYROSINE KINASE;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROTECTION; CELL SURVIVAL; CELLULAR DISTRIBUTION; DEPHOSPHORYLATION; GENE EXPRESSION REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

RODENTIA;

EID: 0032475861     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81780-8     Document Type: Article

References (58)

1. Ahmed, N.N., Franke, T.F., Bellacosa, A., Datta, K., Gonzalez-Portal, M.E., Taguchi, T., Testa, J.R., and Tsichlis, P.N. (1993). The proteins encoded by c-akt and v-akt differ in post-translational modification, subcellular localization and oncogenic potential. Oncogene 8, 1957-1963.
2. Ahmed, N.N., Grimes, H.L., Bellacosa, A., Chan, T.O., and Tsichlis, P.N. (1997). Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc. Natl. Acad. Sci. USA 94, 3627-3632.
3. Alessi, D.R., and Cohen, P (1998). Mechanism of activation and function of protein kinase B. Curr. Opin. Gen. Dev. 8, 55-62.
4. Alessi, D.R., Andjelkovic, M., Caudwell, B., Cron, P., Morrice, N., Cohen, P., and Hemmings, B.A. (1996). Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15, 6541-6551.
5. Alessi, D.R., Deak, M., Casamayor, A., Caudwell, F.B., Morrice, N., Norman, D.G., Gaffney, P., Reese, C.B., MacDougall, C.N., Harbison, D., Ashworth, A., and Bownes, M. (1997). 3-phosphoinositide-dependent protein kinase-1 (PDK1 ): structural and functional homology with the Drosophila DSTPK61 kinase. Curr. Biol. 7, 776-789.
6. Bellacosa, A., Testa, J.R., Staar, S.P., and Tsichlis, P.N. (1991). A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science 254, 274-277.
7. Bellacosa, A., de Feo, D., Godwin, A.K., Bell, D.W., Cheng, J.Q., Altomare, D.A., Wan, M., Dubeau, L., Scambia, G., and Masciullo, V. (1995). Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int. J. Cancer 64, 280-285.
8. Bigner, S.H., Mark, J., Burger, P.C., Mahaley, M.S. Jr., Bullard, D.E., Muhlbaier, L.H., and Bigner, D.D. (1998). Specific chromosomal abnormalities in malignant human gliomas. Cancer Res. 48, 405-411.
9. Cairns, P., Okami, K., Halachmi, S., Harachmi, N., Esteller, M., Herman, J.G., Jen, J., Isaacs, W.B., Bova, G.S., and Sidransky, D. (1997). Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res. 57, 4997-5000.
10. Chaffanet, M., Chauvin, C., Laine, M., Berger, F., Chedin, M., Rost, N., Nissou, M.F., and Benabid, A.L. (1992). EGF receptor amplification and expression in human brain tumours. Eur. J. Cancer 28, 11-17.
11. Cheney, I.W., Johnson, D.E., Vaillancourt, M.T., Avanzini, J., Morimoto, A., Demers, G.W., Wills, K.N., Shabram, P.W., Bolen, J.B., Tavtigian, S.V., and Bookstein R. (1998). Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. Cancer Res. 58, 2331-2334.
12. Cheng, J.Q., Godwin, A.K., Bellacosa, A., Taguchi, T., Franke, T.F., Hamilton, T.C., Tsichlis, P.N., and Testa, J. R. (1992). AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/ threonine kinases, is amplified in human ovarian carcinomas. Proc. Natl. Acad. Sci. USA 89, 9267-9271.
13. Cheng, J.Q., Ruggeri, B., Klein, W.M., Sonoda, G., Altomare, D.A., Watson, D.K., and Testa, J.R. (1996). Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc. Natl. Acad. Sci. USA 93, 3636-3641.
14. Coucovanis, E., and Martin, G.R. (1995). Signals for death and survival: a two-step mechanism for cavitation in the vertebrate embryo. Cell 83, 279-287.
15. Cross, D.A., Alessi, D.R., Cohen, P., Andjelkovich, M., and Hemmings, B.A. (1995). Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789.
16. Downward, J. (1998). Mechanisms and consequences of activation of protein kinase B/Akt. Curr. Opin. Cell. Biol. 10, 262-267.
17. Dudek, H., Datta, S.R., Franke, T.F., Birnbaum, M.J., Yao, R., Cooper, G.M., Segal, R.A., Kaplan, D.R., and Greenberg, M.E. (1997). Regulation of neuronal survival by the serine-threonine protein kinase akt. Science 275, 661-665.
18. Eng, C. (1998). Genetics of Cowden syndrome: through the looking glass of oncology. Int. J. Oncol. 12, 701-710.
19. Furnari, F.B., Lin, H., Huang, H.J.S., and Cavenee, W.K. (1997). Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc. Natl. Acad. Sci. USA 94, 12479-12484.
20. Gavrieli, Y., Sherman, Y., and Ben-Sasson, S.A. (1992). Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119, 493-501.
21. Goldman, A. (1998). Culture and biochemical analysis of cells. In Cells: A Laboratory Manual, D.L. Spector, R.D. Goldman, and L.A. Leinwand, eds. (Plainview, New York: Cold Spring Harbor Laboratory Press), 4.1-4.7.
22. Hausler, P., Papoff, G., Eramo, A., Reif, K., Cantrell, D.A., and Ruberti, G. (1998). Protection of CD95-mediated apoptosis by activation of phosphatidylinositide 3-kinase and protein kinase B. Eur. J. Immunol. 28, 57-69.
23. Hayashi, Y., Koike, M., Matsunami, M., and Hoshino, T. (1988). Effects of fixation time and enzymatic digestion in immunohistochemical demonstration of bromodeoxyuridine in formalin-fixed, paraffin-embedded tissue. J. Histochem. Cytochem. 36, 511-514.
24. Hitoshi, Y., Lorens, J., Kitada, S.I., Fisher, J., LaBarge, M., Ring, H.Z., Francke, U., Reed, J.C., Kinoshita, S., and Nolan, G.P. (1998). Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells. Immunity 8, 461-471.
25. Kauffmann-Zeh, A., Rodriguez-Viciana, P., Ulrich, E., Gilbert, C. Coffer, P., Downward, J., and Evan, G. (1997). Suppression of c-Myc-induced apoptosis by Ras signaling through PI(3)K and PKB. Nature 385, 544-548.
26. Kennedy, S.G., Wagner, A.J., Conzen, S.D., Jordan, J., Bellacosa, A., Tsichlis, P.N., and Hay, N. (1997). The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev. 11, 701-713.
27. Khwaja, A., Rodriguez-Viciana, P., Wennstrom, S., Warne, P.H., and Downward, J. (1997). Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J. 16, 2783-2793.
28. Kinzler, K.W., and Vogelstein, B. (1998). Landscaping the cancer terrain. Science 280, 1036-1037.
29. Kulik, G., Klippel, A., and Weber, M.J. (1997). Antiapoptotic signaling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol. Cell. Biol. 17, 1595-1606.
30. Kyriakis, J.M., and Avruch, J. (1996). Sounding the alarm: protein kinase cascades activated by stress and inflammation. J. Biol. Chem. 271, 24313-24316.
31. Li, D.-M., and Sun, H. (1997). TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor β. Cancer Res. 57, 2124-2129.
32. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S.I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997). PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943-1947.
33. Liaw, D., Marsh, D.J., Li, J., Dahia, P.L.M., Wang, S.I., Zheng, Z., Bose, S., Call, K.M., Tsou, H.C., Peacocke, M., Eng, C., and Parsons, R. (1997). Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet. 16, 64-67.
34. Lo, S.H., Weisberg, E., and Chen, L.B. (1994). Tensin: a potential link between the cytoskeleton and signal transduction. Bioessays 16, 817-823.
35. Maehama, T., and Dixon, J.E. (1998). The tumor suppressor, PTEN/ MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273, 13375-13378.
36. Marsh, D.J., Coulon, V., Lunetta, K.L., Rocca-Serra, P., Dahia, P.L.M., Zheng, Z., Liaw, D., Caron, S., Duboue, B., Lin, A.Y., et al. (1998). Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum. Mol. Genet. 7, 507-515.
37. Meier, R., Alessi, D.R., Cron, P., Andjelkovic, M., and Hemmings, B.A. (1997). Mitogenic activation, phosphorylation, and nuclear translocation of protein kinase B beta. J. Biol. Chem. 272, 30491-30497.
38. Mishina, Y., Sukuki, A., Veno, N., and Behringer, R.R. (1995). BMPR encodes a type 1 bone morphogenetic protein-receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev. 9, 3027-3037.
39. Myers, M.P., Stolarov, J.P., Eng, C., Li, J., Wang, S.I., Wigler, M.H., Parsons, R., and Tonks, N.K. (1997). PTEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc. Natl. Acad. Sci. USA 94, 9052-9057.
40. Nishina, H., Fischer, K.D., Radvanyi, L., Shahinian, A., Hakem, R., Rubie, E.A., Bernstein, A., Mak, T.W., Woodgett, J.R., and Penninger, J. (1997). Stress-signaling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3. Nature 385, 350-353.
41. Rasheed, B.K.A., Stenzel, T.T., McLendon, R.E., Parsons, R., Friedman, A.H., Fridman, H.S., Bigner, D.D., and Bigner, S.H. (1997). PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res. 57, 4187-4190.
42. Rhei, E., Kang, L., Bogomolniy, F., Federici, M.G., Borgen, P.I., and Boyd, J. (1997). Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res. 57, 3657-3659.
43. Sasaki, T., Hazeki, K., Hazeki, O., Ui, M., and Katada, T. (1996). Focal adhesion kinase (p125FAK) and paxillin are substrates for sphingomyelinase-induced tyrosine phosphorylation in Swiss 3T3 fibroblasts. Biochem. J. 315, 1035-1040.
44. Schmid, I., Uittenbogaart, C.H., and Giorgi, J.V. (1994). Sensitive method for measuring apoptosis and cell surface phenotype in human thymocytes by flow cytometry. Cytometry 15, 12-20.
45. Smits, A., and Funa, K. (1998). Platelet-derived growth factor (PDGF) in primary brain tumours of neuroglial origin. Histol. Histopathol. 13, 511-520.
46. Snow, M.H.L. (1977). Gastrulation in the mouse: growth and regionalization of the epiblast. J. Embryol. Exp. Morph. 42, 293-303.
47. Staal, S.P., and Hartley, J.W. (1988). Thymic lymphoma induction by the AKT8 murine retrovirus. J. Exp. Med. 167, 1259-1264.
48. Staveley, B.E., Ruel, L., Jin, J., Stambolic, V., Mastronardi, F.G., Heitzler, P., Woodgett, J.R., and Manoukian, A.S. (1998). Genetic analysis of protein kinase B (AKT) in Drosophila. Curr. Biol. 8, 599-602.
49. Steck, P.A., Pershouse, M.A., Jasser, S.A., Yung, W.K.A., Lin, H., Ligon, A.H., Langford, L.A., Baumgard, M.L., Hattier, T., Davis, T., et al. (1997). Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet. 15, 356-362.
50. Stephens, L., Anderson, K., Stokoe, D., ErdjumentBromage, H., Painter, G.F., Holmes, A.B., Gaffney, P.R.J., Reese, C.B., McCormick, F., Tempst, P., Coadwell, J., and Hawkins, P.T. (1998). Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 279, 710-714.
51. Stokoe, D., Stephens, L.R., Copeland, T., Gaffney, P.R., Reese, C.B., Painter, G.F., Holmes, A.B., McCormick, F., and Hawkins, P.T. (1997). Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science 277, 567-570.
52. Strutz, F., Okada, H., Lo, C.W., Danoff, T., Carone, R.L., Tomaszevski, J.E., and Neilson, E.G. (1995) Identification and characterization of a fibroblast marker: FSP1. J. Cell Biol. 130, 393-405.
53. Takahashi, J.A., Fukumoto, M., Igarashi, K., Oda, Y., Kikuchi, H., and Hatanaka, M. (1992). Correlation of basic fibroblast growth factor expression levels with the degree of malignancy and vascularity in human gliomas. J. Neurosurg. 76, 792-798.
54. Tamura, M., Gu, J., Matsumoto, K., Aota, S., Parsons, R., and Yamada, K.M. (1998). Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280, 1614-1617.
55. Tashiro, H., Blazes, M.S., Wu, R., Cho, K.R., Bose, S., Wang, S.I., Li, J., Parsons, R., and Ellenson, L.H. (1997). Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res. 57, 3935-3940.
56. Teng, D.H-F., Hu, R., Lin, H., Davis, T., Illiev, D., Frye, C., Swedlund, B., Hansen, K.L., Vinson, V.L., Gumpper, K.L., et al. (1997). MMAC1/ PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res. 57, 5221-5225.
57. Ulrich, E., Duwel, A., Kauffmann-Zeh, A., Gilbert, C., Lyon, D., Rudkin, B., Evan, G., and Martin-Zanca, D. (1998). Specific TrkA survival signals interfere with different apoptotic pathways. Oncogene 16, 825-832.
58. Welch, H., Eguinoa, A., Stephens, L.A., and Hawkins, P.T. (1998). Protein kinase B and Rac are activated in parallel within a phosphatidylinositide 3OH-kinase-controlled signaling pathway. J. Biol. Chem. 273, 11248-11256.